Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control study

被引:0
|
作者
Atsushi Ohgushi
Takayuki Ohtani
Natsumi Nakayama
Shigeo Asai
Yoshiyuki Ishii
Atsuo Namiki
Manabu Akazawa
Hirotoshi Echizen
机构
[1] Japan Labour Health and Welfare Organization Kanto Rosai Hospital,Department of Hospital Pharmacy
[2] Japan Labour Health and Welfare Organization Kanto Rosai Hospital,Department of Cardiology
[3] Meiji Pharmaceutical University,Department of Public Health and Epidemiology
[4] Meiji Pharmaceutical University,Department of Pharmacotherapy
关键词
Non-valvular atrial fibrillation; Warfarin; PT-INR; Japanese; Elderly patients;
D O I
10.1186/s40780-015-0036-1
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
    Proietti, Marco
    Senoo, Keitaro
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    SCIENTIFIC REPORTS, 2016, 6
  • [22] Naxos study: risk of bleeding with oral anticoagulants in non-valvular atrial fibrillation patients in France
    Danchin, N.
    Steg, P. G.
    Hanon, O.
    Mahe, I
    Falissard, B.
    Belhassen, M.
    Dalon, F.
    Gollety, S.
    Cotte, F. E.
    Van-Ganse, E.
    EUROPEAN HEART JOURNAL, 2020, 41 : 643 - 643
  • [23] Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
    Matsui, Kunihiko
    Kusano, Kengo
    Akao, Masaharu
    Tsuji, Hikari
    Hiramitsu, Shinya
    Hatori, Yutaka
    Odakura, Hironori
    Ogawa, Hisao
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin
    Lip, G. Y. H.
    Pan, X.
    Kamble, S.
    Kawabata, H.
    Mardekian, J.
    Masseria, C.
    Bruno, A.
    Phatak, H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1085 - 1085
  • [25] The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation: comment
    Mantha, S.
    Moll, S.
    Hilden, P.
    Devlin, S.
    Rose, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (10) : 2083 - 2084
  • [26] Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants
    Chang, Kuo-Hsuan
    Chen, Chiung-Mei
    Wang, Chun-Li
    Tu, Hui-Tzu
    Huang, Yu-Tung
    Wu, Hsiu-Chuan
    Chang, Chien-Hung
    Chang, Shang-Hung
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [27] Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies
    Wang, Yimin Pearl
    Kehar, Rohan
    Iansavitchene, Alla
    Lazo-Langner, Alejandro
    BLOOD, 2019, 134
  • [28] Comparison of Major Bleeding Risk and Associated Costs Among Newly Anticoagulated Non-valvular Atrial Fibrillation Patients
    Deitelzweig, Steven
    Bruno, Amanda
    Tate, Natalie
    Ogbonnaya, Augustina
    Shah, Manan
    Farrelly, Eileen
    Lokhandwala, Tasneem
    Gupta, Kiran
    Eaddy, Michael
    CIRCULATION, 2015, 132
  • [29] Risk of Stroke and Major Bleeding for Dabigatran, Rivaroxaban, and Warfarin Compared to Apixaban Among Non-Valvular Atrial Fibrillation Patients in the United States Medicare Population
    Amin, Alpesh
    Keshishian, Allison
    Trocio, Jeffrey
    Dina, Oluwaseyi
    Le, Hannah
    Rosenblatt, Lisa
    Liu, Xianchen
    Mardekian, Jack
    Zhang, Qisu
    Baser, Onur
    Vo, Lien
    CIRCULATION, 2017, 136
  • [30] Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States
    Lip, Gregory Y. H.
    Pan, Xianying
    Kamble, Shital
    Kawabata, Hugh
    Mardekian, Jack
    Masseria, Cristina
    Bruno, Amanda
    Phatak, Hemant
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (09) : 752 - 763